Robert J. Mentz, MD has been named the new Editor-in-Chief of the Journal of Cardiac Failure, the official journal of the Heart Failure Society of America and the Japanese Heart Failure Society.

Dr. Mentz is an Associate Professor of Medicine and Chief of the Heart Failure Section at Duke University and assists with the care of patients with heart failure, cardiac transplants, and ventricular assist devices at Duke University Hospital. He is an NIH and industry-funded clinical trialist involved in ongoing trials designed to inform the care of cardiac patients.

Author of more than 300 peer-reviewed publications, Mentz has also authored several book chapters (including Braunwald’s Heart Failure textbook), was a topic editor for the Heart Failure Self-Assessment Program (HF-SAP) and a writer for the ACCSAP on heart failure. He has also served as an Associate Editor for Circulation: Heart Failure. 

“I am honored to take on the role of editor-in-chief of the Journal of Cardiac Failure,” said Mentz. “I look forward to serving the HFSA members as well as the broader heart failure community as we work to publish high-quality original research, reviews, scientific statements and position pieces that are interesting and practice changing. I’m eager to collaborate with the talented editorial team and HFSA leadership to elevate the journal to new heights and bring increased awareness to the field.”

Launched in 1994 and a joint endeavor by the Heart Failure Society of America and the Japanese Heart Failure Society, the Journal of Cardiac Failure publishes peer-reviewed manuscripts of interest to clinicians and researchers in the field of heart failure and related disciplines. These include original communications of scientific importance and review articles involving clinical research, health services and outcomes research, animal studies, and bench research with potential clinical applications to heart failure. The Journal also publishes manuscripts that report the design of ongoing clinical trials and editorial perspectives that comment on new developments pertinent to the field of heart failure or manuscripts published in other journals.

Mentz will begin his term as Editor-in-Chief on December 1, 2020.